Zümre ARICAN, Ferah YILDIZ, Melis GÜLTEKİN, Gökhan ÖZYİĞİT, Barbaros AYDIN, Berna AKKUŞ, Sezin YÜCE SARI, İlknur Bilkay GÖRKEN, Cem ÖNAL, Müge AKMANSU, Özge petek ERPOLAT, Bilge GÜRSEL, Didem ÇOPAN ÖKSÜZ, Şefika Arzu ERGEN

The Comparision of Breast Cancer in the Young and Elderly Patients

OBJECTIVETo compare the tumor characteristics, treatment approaches, recurrence patterns and survival resultsrates of young and elderly patients with breast cancer.METHODSIn this study, Between between 2000-2013, a total of 779 patients were treated for breast cancer at nineradiation oncology departments were evaluated retrospectively. Three-hundred eight-four of these patients were young (≤35 years), and 395 of those the patients were elderly (≥70 years).RESULTSYoung patients were more likely to present with aggressive tumor features. They were more often receivedcomprehensive lymphatic irradiation, tumor bed boost and intense chemotherapy. No difference was foundfor 5 and 10-year loco-regional recurrence- free survival rates were (96% and 93% for young, 97% and 97%for elderly). The 5 and 10-year distant recurrence- free survival rates were lower in the young patients (77%and 67% for young, 85% and 85% for elderly, p

PDF

___

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90.
2. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review. 1975-2014. Available at: https://seer.cancer.gov/ csr/1975_2014/. Accessed, April 2017. Bethesda, MD: National Cancer Institute, 2017.
3. Chung M, Chang HR, Bland KI, Wanebo HJ. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77(1):97–103.
4. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, et al. Ten year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 2009;73(3):734–44.
5. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26(20):3324–30.
6. Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer 2004;100(9):1807–13.
7. Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 2013;105(13):978–88.
8. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS One 2009;4(11):7695.
9. Grumpelt AM, Ignatov A, Tchaikovski SN, Burger E, Costa SD, Eggemann H. Tumor characteristics and therapy of elderly patients with breast cancer. J Cancer Res Clin Oncol 2016;142(5):1109–16.
10.Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12(5):888–94.
11.Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990;8(4):591–8.
12.de Kruijf EM, Bastiaannet E, Rubertá F, de Craen AJ, Kuppen PJ, Smit VT, van de Velde CJ, Liefers GJ. Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients. Mol Oncol 2014;8(5):1014–25.
13.Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, et al. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 2011;29(1):18–20.
14.Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, et al. Very young women (<35 years) with operable breast cancer: features of diseaseat presentation. Ann Oncol 2002;13(2):273–9.
15.Kheirelseid EH, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, et al. Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 2011;11:383.
16.Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 2010; 21(10):1974–81.
17.Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):2893–917.
18.Axelrod D, Smith J, Kornreich D, Grinstead E, Singh B, Cangiarella J, et al. Breast cancer in young women. J Am Coll Surg 2008;206(6):1193–203.
19.Pierga JY, Girre V, Laurence V, Asselain B, Diéras V, Jouve M, et al. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast 2004;13(5):369–75.
20.Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer 2004;101(6):1302–10.
21.Laird-Fick HS, Gardiner JC, Tokala H, Patel P, Wei S, Dimitrov NV. HER2 status in elderly women with breast cancer. J Geriatr Oncol 2013;4(4):362–7.
22.Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92(7):550–6.
23.Bergman L, Kluck HM, van Leeuwen FE, Crommelin MA, Dekker G, Hart AA, et al. The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a populationbased study. Eur J Cancer 1992;28(8-9):1475–80.
24.Greer LT, Rosman M, Charles Mylander W, Liang W, Buras RR, Chagpar AB, et al. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women. Breast J 2014;20(2):147–53.
25.Hamaker ME, Bastiaannet E, Evers D, Water Wv, Smorenburg CH, Maartense E, et al. Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer 2013;49(3):545–52.
26.Gajdos C1, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL. The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 2001;192:698–707.
27.Wang J, Wang J, Li Q, Zhang P, Yuan P, Ma F, Luo Y, et al. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts. Oncotarget 2017;8(27):44851–9.
28.Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
29.Wallgren A, Bonetti M, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Holmberg SB, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 2003;21(7):1205–13.
30.Rudra S, Yu DS, Yu ES, Switchenko JM, Mister D, Torres MA. Locoregional and distant recurrence patterns in young versus elderly women treated for breast cancer. Int J Breast Cancer 2015;2015:213123.
31.Goldhirsch A, Glick JH, Gelber RD, Senn HJ. International Consensus Panel on the treatment of primary breast cancer. V: Update 1998. Recent Results Cancer Res 1998;152:481–97.
32.Brunello A, Basso U, Pogliani C, Jirillo A, Ghiotto C, Koussis H, et al. Adjuvant chemotherapy for elderly patients (>or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients. Ann Oncol 2005;16(8):1276–82.
33.Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol 2005;23(4):783–91.
34.Mustacchi G, Cazzaniga ME, Pronzato P, De Matteis A, Di Costanzo F, Floriani I; NORA Study Group. Breast cancer in elderly women: a different reality? Results from the NORA study. Ann Oncol 2007;18(6):991–6.
35.Bastiaannet E, Portielje JE, van de Velde CJ, de Craen AJ, van der Velde S, Kuppen PJ, et al. Lack of survival gain for elderly women with breast cancer. Oncologist 2011;16(4):415–23.
36.Enger SM, Thwin SS, Buist DS, Field T, Frost F, Geiger AM, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 2006;24(27):4377–83.
37.Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20- year follow-up of a randomised phase 3 trial. Lancet Oncol 2015;16(1):47–56.
38.Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breastconserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001;19(6):1688–97.
39.Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, et al. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Ann Surg Oncol 2016;23(10):3212–20.
40.American Cancer Society. Breast Cancer Facts&Figures 2017-2018. Atlanta: American Cancer Society, Inc. 2017.